Hepatocellular carcinoma is one of the leading causes of cancer related death in the world.
Biannual surveillance for the disease in patients with cirrhosis and in high risk carriers of …

Hepatocellular carcinoma (HCC) represents a significant contributor to cancer-related
morbidity and mortality with increasing incidence in both developing and developed …

Simple Summary The role of stereotactic body radiotherapy (SBRT), which can deliver high
radiation doses to focal tumors, has greatly increased in not only early-stage hepatocellular …

Stereotactic body radiotherapy (SBRT), a type of external beam radiotherapy, yields local
control of hepatocellular carcinoma (HCC) at rates as high as 90%. SBRT has been …

Simple Summary Radiotherapy is rapidly turning into a crucial component of
multidisciplinary treatment for liver cancer because many patients are not surgical treatment …

Historically, radiation therapy was not considered in treatment of liver tumors owing to the
risk of radiation-induced liver disease. However, development of highly conformed radiation …

Background: Hepatocellular carcinoma (HCC) incidence is rising worldwide, especially due
to increased detection of early-stage or small-sized tumors. Nevertheless, most of the …

Hepatocellular carcinoma (HCC) remains the most common form of liver cancer, accounting
for 90% of all primary liver cancers. Up to 30% of HCC cases could be small (2–3 cm in …

PURPOSE: Magnetic resonance–guided radiation therapy (MRgRT) has recently become
commercially available, offering the opportunity to accurately image and target moving …

The role of radiotherapy in the treatment of hepatocellular carcinoma (HCC) has evolved
over the past few decades with the advancement of technology and improved imaging …